| --- |
| license: cc-by-nc-4.0 |
| task_categories: |
| - tabular-classification |
| - tabular-regression |
| language: |
| - en |
| tags: |
| - synthetic |
| - healthcare |
| - genomics |
| - variant-calling |
| - vcf |
| - vep |
| - cadd |
| - clinvar |
| - gnomad |
| - rna-seq |
| - bulk-rna-seq |
| - single-cell |
| - scrna-seq |
| - pbmc |
| - gene-expression |
| - polygenic-risk-score |
| - prs |
| - pharmacogenomics |
| - pgx |
| - cpic |
| - pharmgkb |
| - cyp2d6 |
| - cyp2c19 |
| - ancestry |
| - grch38 |
| - hg38 |
| - titv |
| - hardy-weinberg |
| - tabula-sapiens |
| - gtex |
| - 10x-genomics |
| pretty_name: HLT-013 Synthetic Multi-Modal Genomics Dataset (Sample Preview) |
| size_categories: |
| - 1K<n<10K |
| --- |
| |
| # HLT-013 — Synthetic Multi-Modal Genomics Dataset (Sample Preview) |
|
|
| **A free, schema-identical preview of the full HLT-013 commercial product from [XpertSystems.ai](https://xpertsystems.ai).** |
|
|
| A **fully synthetic** multi-modal genomics dataset combining **variant calls** (VCF-style with VEP/CADD/ClinVar/gnomAD annotations), **bulk RNA-seq gene expression** (5 tissues × 2,000 genes), **single-cell RNA-seq PBMC profiles** (10 cell types), **polygenic risk scores** (50 traits across 5 disease domains), and **pharmacogenomics star allele calls** (25 CPIC-actionable genes) — all linked through 1,000 individuals across 5 ancestry superpopulations (EUR/AFR/EAS/AMR/SAS, gnomAD-calibrated). |
|
|
| > ⚠️ **PRIVACY & SYNTHETIC NATURE** |
| > Every record in this dataset is **100% synthetic**. **No real patient data, no PHI, no real genome sequences, no real variant calls.** Population-level distributions match published gnomAD / ClinVar / VEP / CPIC / Tabula Sapiens benchmarks but the genomic profiles are computationally generated. |
|
|
| --- |
|
|
| ## What's in this sample |
|
|
| **1,000 individuals × 6 multi-modal genomic data tables linked by `sample_id`.** |
| |
| | File | Rows × Cols | Description | |
| |---|---|---| |
| | `cohort_manifest.csv` | 1,000 × 10 | Individual master — ancestry, sex, age, sequencing type, mean coverage, pct bases ≥20x, consent tier | |
| | `variants_annotated.csv` | 600 × 14 | VCF-style: CHROM/POS/RSID/REF/ALT/GT/GQ/DP + VEP consequence + CADD Phred + ClinVar sig + gnomAD AF + HWE p-value | |
| | `gene_expression.csv` | 2,000 × 7 | Bulk RNA-seq gene panel — mean log2TPM, SD, CV, % expressed, housekeeping flag | |
| | `scrna_pbmc.csv` | ~1,900 × 11 | Single-cell PBMC: cell type, cluster ID, UMAP coords, n_genes, n_counts, pct_mito, doublet score | |
| | `polygenic_risk_scores.csv` | 1,000 × 152 | 50 PRS traits × (raw score + ancestry-adjusted percentile + risk tier) per individual | |
| | `pharmacogenomics.csv` | 1,000 × 102 | 25 PGx genes × (star allele class + CPIC recommendation + ACMG actionable + drug-specific guidance) | |
| | `metadata.json` | — | Run manifest: seed, genome build, ancestry distribution, Ti/Tv, tissue/cell-type/PRS/PGx counts | |
| |
| **Total:** ~2.4 MB across 8 files. |
|
|
| --- |
|
|
| ## Schema highlights |
|
|
| ### `cohort_manifest.csv` (10 columns) |
| |
| `sample_id`, `ancestry_superpop` (EUR/AFR/EAS/AMR/SAS), `sex`, `age`, `cohort_id`, `genome_build` (GRCh38), `sequencing_type` (WGS/WES), `mean_coverage` (numeric, 30x WGS / 100x WES mix), `pct_bases_20x` (QC metric), `consent_tier` (research/clinical/broad) |
|
|
| ### `variants_annotated.csv` (14 columns) |
| |
| **Position:** `CHROM` (1-22, X), `POS` (genomic coordinate), `RSID` (rs identifier), `REF`, `ALT`, `variant_type` (SNP/InDel) |
|
|
| **Genotype:** `GT` (0/0, 0/1, 1/1), `GQ` (genotype quality 0-99), `DP` (read depth) |
|
|
| **Annotation:** `consequence` (VEP terms: intergenic / intron / synonymous / missense / 3'UTR / 5'UTR / splice_region / stop_gained / splice_donor / splice_acceptor / frameshift / inframe_indel), `CADD_phred` (deleteriousness 0-50+), `ClinVar_sig` (Benign / Likely_benign / VUS / Likely_pathogenic / Pathogenic), `AF_gnomAD` (allele frequency 0-1) |
|
|
| **Population genetics:** `HWE_pval` (Hardy-Weinberg Equilibrium p-value) |
|
|
| ### `gene_expression.csv` (7 columns) |
| |
| `gene_id` (ENSG-style), `gene_name`, `mean_log2TPM`, `sd_log2TPM`, `cv` (coefficient of variation), `pct_expressed` (% of individuals with detectable expression), `is_housekeeping` (flag for stably-expressed reference genes) |
| |
| ### `scrna_pbmc.csv` (11 columns) |
|
|
| `sample_id`, `cell_barcode`, `cell_type` (10 types: CD4_T_naive, CD4_T_memory, CD8_T_cytotoxic, B_cell_naive, B_cell_memory, NK_cell, Monocyte_classical, Monocyte_nonclassical, pDC, Platelet), `cluster_id`, `UMAP_1`, `UMAP_2`, `n_genes`, `n_counts`, `pct_mito`, `doublet_score`, `cell_type_confidence` |
|
|
| ### `polygenic_risk_scores.csv` (152 columns) |
|
|
| `sample_id`, `ancestry`, plus **50 traits × 3 fields each**: |
|
|
| - `PRS_<trait>` — raw polygenic score |
| - `PRS_<trait>_pct` — ancestry-adjusted percentile (0-100) |
| - `PRS_<trait>_tier` — risk tier (Low/Intermediate/High) |
|
|
| **50 traits across 5 domains:** |
| - **CVD (10):** coronary_artery_disease, atrial_fibrillation, heart_failure, hypertension, stroke, peripheral_artery_disease, abdominal_aortic_aneurysm, hypertrophic_cardiomyopathy, dilated_cardiomyopathy, long_qt_syndrome |
| - **Metabolic (10):** type2_diabetes, BMI, LDL_cholesterol, HDL_cholesterol, triglycerides, fasting_glucose, HbA1c, type1_diabetes, obesity, NAFLD |
| - **Oncology (10):** breast_cancer, prostate_cancer, colorectal_cancer, lung_cancer, melanoma, ovarian_cancer, pancreatic_cancer, glioma, leukemia, lymphoma |
| - **Autoimmune (10):** rheumatoid_arthritis, type1_diabetes_autoimmune, MS, lupus, psoriasis, IBD_crohns, IBD_ulcerative_colitis, celiac, asthma, atopic_dermatitis |
| - **Psychiatric (10):** depression, bipolar, schizophrenia, anxiety, ADHD, autism, alzheimers, parkinsons, alcohol_dependence, smoking_behavior |
|
|
| ### `pharmacogenomics.csv` (102 columns) |
|
|
| `sample_id`, `ancestry`, plus **25 genes × 4 fields each**: |
|
|
| - `PGx_<gene>_class` — predicted phenotype (NM=Normal Metabolizer / IM=Intermediate / PM=Poor / RM=Rapid / UM=Ultrarapid) |
| - `PGx_<gene>_CPIC` — CPIC dosing recommendation (Standard/Reduce/Increase/Avoid) |
| - `PGx_<gene>_ACMG_actionable` — ACMG SF v3.2 actionable flag |
| - `PGx_<gene>_recommendation` — drug-specific guidance text |
|
|
| **25 genes (CPIC Level A or B):** CYP2D6, CYP2C19, CYP2C9, CYP3A5, CYP2B6, CYP1A2, TPMT, NUDT15, DPYD, SLCO1B1, VKORC1, UGT1A1, HLA-B, HLA-A, CYP4F2, IFNL3, G6PD, RYR1, CACNA1S, ABCG2, F5, MTHFR, NAT2, ATM, BRCA1 |
|
|
| --- |
|
|
| ## Calibration source story |
|
|
| The full HLT-013 generator anchors all distributions to authoritative genomics references: |
|
|
| - **gnomAD v4 (Karczewski et al. 2020)** — Population allele frequencies, ancestry superpopulation proportions |
| - **VEP (McLaren et al. 2016)** — Variant Effect Predictor consequence annotation |
| - **ClinVar (Landrum et al. 2018)** — Clinical variant significance database |
| - **CADD (Rentzsch et al. 2019)** — Combined Annotation Dependent Depletion scores |
| - **CPIC** — Clinical Pharmacogenetics Implementation Consortium dosing guidelines |
| - **PharmGKB** — Gene-drug interaction knowledge base |
| - **10x Genomics PBMC 10k reference** — Single-cell PBMC cell type proportions |
| - **Tabula Sapiens (Quake Lab)** — Cross-tissue cell type catalog |
| - **GTEx Consortium** — Tissue-specific gene expression |
| - **PGS Catalog (Lambert et al. 2021)** — Polygenic score trait coverage |
| - **ACMG SF v3.2** — Secondary findings actionable variant list |
|
|
| ### Sample-scale validation scorecard |
|
|
| | Metric | Observed | Target | Status | Source | |
| |---|---|---|---|---| |
| | EUR ancestry share | 40.2% | 40% ± 5% | ✅ PASS | gnomAD v4 | |
| | Ancestry superpop count | 5 | 5 | ✅ PASS | gnomAD | |
| | Ti/Tv ratio | 2.31 | 2.06 ± 0.80 | ✅ PASS | Wang et al. (2015) | |
| | ClinVar P/LP rate | 2.3% | 2.5% ± 2.5% | ✅ PASS | ClinVar | |
| | Mean coverage | 42.1x | 42 ± 10 | ✅ PASS | Clinical genomics QC | |
| | Cell type diversity | 10 | 10 | ✅ PASS | 10x Genomics PBMC 10k | |
| | PRS trait count | 50 | 50 | ✅ PASS | PGS Catalog | |
| | PGx gene count | 25 | 25 | ✅ PASS | CPIC Level A/B | |
| | CYP2D6 NM rate | 66.7% | 65% ± 15% | ✅ PASS | CPIC + PharmGKB | |
| | Expression tissue count | 5 | 5 | ✅ PASS | Tabula Sapiens / GTEx | |
|
|
| **Grade: A+ (100/100) — verified across 6 random seeds (42, 7, 123, 2024, 99, 1).** |
|
|
| --- |
|
|
| ## Loading examples |
|
|
| ### Pandas — explore the cohort |
|
|
| ```python |
| import pandas as pd |
| |
| cohort = pd.read_csv("cohort_manifest.csv") |
| variants = pd.read_csv("variants_annotated.csv") |
| prs = pd.read_csv("polygenic_risk_scores.csv") |
| pgx = pd.read_csv("pharmacogenomics.csv") |
| |
| # Ancestry distribution |
| print(cohort["ancestry_superpop"].value_counts(normalize=True).round(3)) |
| |
| # Variant consequence breakdown |
| print(variants["consequence"].value_counts(normalize=True).round(3)) |
| |
| # ClinVar significance |
| print(variants["ClinVar_sig"].value_counts()) |
| ``` |
|
|
| ### Variant filtering |
|
|
| ```python |
| import pandas as pd |
| |
| variants = pd.read_csv("variants_annotated.csv") |
| |
| # High-impact variants (Pathogenic + CADD > 25) |
| high_impact = variants[ |
| (variants["ClinVar_sig"].isin(["Pathogenic", "Likely_pathogenic"])) | |
| (variants["CADD_phred"] > 25) |
| ] |
| print(f"High-impact variants: {len(high_impact)}") |
| |
| # Rare variants (gnomAD AF < 1%) |
| rare = variants[variants["AF_gnomAD"] < 0.01] |
| print(f"Rare variants: {len(rare)}") |
| |
| # HWE-departure variants |
| hwe_violations = variants[variants["HWE_pval"] < 0.001] |
| print(f"HWE violations: {len(hwe_violations)}") |
| ``` |
|
|
| ### PRS risk stratification |
|
|
| ```python |
| import pandas as pd |
| |
| prs = pd.read_csv("polygenic_risk_scores.csv") |
| |
| # Top 10% CAD risk individuals |
| high_cad = prs[prs["PRS_coronary_artery_disease_pct"] >= 90] |
| print(f"High CAD risk: {len(high_cad)} individuals") |
| |
| # Multi-trait risk profile |
| risk_traits = ["coronary_artery_disease", "type2_diabetes", "breast_cancer"] |
| for trait in risk_traits: |
| tier_col = f"PRS_{trait}_tier" |
| if tier_col in prs.columns: |
| print(f"\n{trait} risk tier distribution:") |
| print(prs[tier_col].value_counts(normalize=True).round(3)) |
| ``` |
|
|
| ### PGx phenotype distribution |
|
|
| ```python |
| import pandas as pd |
| |
| pgx = pd.read_csv("pharmacogenomics.csv") |
| |
| # CYP2D6 phenotype by ancestry |
| print(pd.crosstab(pgx["ancestry"], pgx["PGx_CYP2D6_class"], normalize="index").round(3)) |
| |
| # Actionable findings (ACMG SF v3.2) |
| actionable_cols = [c for c in pgx.columns if c.endswith("_ACMG_actionable")] |
| n_actionable = pgx[actionable_cols].sum(axis=1) |
| print(f"\nIndividuals with ≥1 actionable PGx finding:") |
| print(f" None: {(n_actionable == 0).sum()}") |
| print(f" 1 gene: {(n_actionable == 1).sum()}") |
| print(f" 2+ genes: {(n_actionable >= 2).sum()}") |
| ``` |
|
|
| ### scRNA-seq cell type analysis |
|
|
| ```python |
| import pandas as pd |
| |
| scrna = pd.read_csv("scrna_pbmc.csv") |
| |
| # Cell type proportions per sample |
| cell_pcts = scrna.groupby("sample_id")["cell_type"].value_counts(normalize=True).unstack(fill_value=0) |
| print("Mean cell type proportions:") |
| print(cell_pcts.mean().sort_values(ascending=False).round(3)) |
| |
| # QC metrics by cell type |
| print("\nQC metrics by cell type:") |
| print(scrna.groupby("cell_type")[["n_genes", "pct_mito", "doublet_score"]].mean().round(2)) |
| ``` |
|
|
| ### Hugging Face Datasets |
|
|
| ```python |
| from datasets import load_dataset |
| |
| ds = load_dataset("xpertsystems/hlt013-sample", data_files={ |
| "cohort": "cohort_manifest.csv", |
| "variants": "variants_annotated.csv", |
| "expression": "gene_expression.csv", |
| "scrna": "scrna_pbmc.csv", |
| "prs": "polygenic_risk_scores.csv", |
| "pgx": "pharmacogenomics.csv", |
| }) |
| print(ds) |
| ``` |
|
|
| --- |
|
|
| ## Suggested use cases |
|
|
| - **Variant prioritization ML** — train classifiers on CADD + ClinVar + AF features to predict pathogenicity |
| - **PRS-disease prediction modeling** — multi-trait ML for absolute risk stratification |
| - **Ancestry imputation** — train ancestry callers from variant features |
| - **Variant Effect Predictor pipeline testing** — schema-compliant data for VEP/SnpEff annotation pipeline development |
| - **Pharmacogenomic CDS rules engine testing** — populate PGx clinical decision support systems |
| - **scRNA-seq cell type classification** — train cell type callers from gene expression + UMAP coordinates |
| - **HWE violation detection** — flag spurious genotype calls or population structure |
| - **Multi-modal genomics integration** — joint modeling across variants + expression + PRS + PGx |
| - **Clinical genomics LIMS testing** — populate clinical genomics pipelines with realistic synthetic patients |
| - **Healthcare AI pretraining** — pretrain models on synthetic genomic profiles before fine-tuning on real biobank data |
| - **Educational use** — graduate genomics, biostatistics, and precision medicine coursework |
|
|
| --- |
|
|
| ## Sample vs. full product |
|
|
| | Aspect | This sample | Full HLT-013 product | |
| |---|---|---| |
| | Individuals | 1,000 | 100,000+ (default) up to 1M | |
| | Variants per individual | 600 representative | Full WGS ~6.5M variants | |
| | Genes (bulk expression) | 2,000 | Full transcriptome ~20,000 genes | |
| | scRNA cells per sample | ~2 (sampled) | ~200 cells per sample | |
| | PRS traits | 50 | 50 (full coverage) | |
| | PGx genes | 25 | 25 (full CPIC Level A/B coverage) | |
| | Schema | identical | identical | |
| | Calibration | identical | identical | |
| | License | CC-BY-NC-4.0 | Commercial license | |
|
|
| The full product unlocks: |
| - **Up to 1M individuals** for biobank-scale genomic ML training |
| - **Full WGS variant calls** (~6.5M variants per individual) |
| - **Full transcriptome** (20,000+ genes) |
| - **Dense scRNA-seq profiles** (200+ cells per sample) |
| - **GWAS summary statistics** for the 50 PRS traits |
| - **Family pedigrees** for trio/quartet analysis |
| - Commercial use rights |
|
|
| **Contact us for the full product.** |
|
|
| --- |
|
|
| ## Limitations & honest disclosures |
|
|
| - **Sample is preview-only.** 1,000 individuals × 600 representative variants is enough to demonstrate schema and calibration, but is **not statistically sufficient** for serious GWAS, PRS development, or rare variant analysis. Use the full product (100K+) for serious work. |
| - **Variant set is sub-sampled.** Each individual carries 600 representative variants (mix of SNPs + InDels), not the ~6.5M variants from full WGS. Variant positions are real-coordinate-valid but sparse. |
| - **scRNA-seq cells per sample are sparse (~2 cells/sample at preview scale).** Real PBMC scRNA-seq experiments yield 200-1000 cells per sample. The sample compresses this for size — full product has dense per-sample profiles. |
| - **Gene expression is panel-summary, not per-individual.** The `gene_expression.csv` file gives population-level summary statistics (mean log2TPM, SD, CV) across the 1,000 individuals, NOT individual-specific TPM values. For per-individual expression matrices, use the full product. |
| - **Housekeeping gene flag rate runs slightly high (~7.5% vs typical 1-3%).** The generator marks more genes as housekeeping than strict biological definitions. Cross-reference with HK genes lists (Eisenberg & Levanon 2013) if exact housekeeping calls matter. |
| - **Ti/Tv ratio variance is high at 600-variant sample scale (1.78-2.68 across seeds vs target 2.06).** This is small-sample noise — full WGS at 6.5M variants converges tightly to the gnomAD target. |
| - **RSIDs are synthetic.** Generated RSIDs follow the rsXXXXXXX format but do NOT correspond to real dbSNP entries. |
| - **gnomAD AF values are sampled from realistic distributions but are NOT real allele frequencies.** Do not use this data for variant frequency reporting. |
| - **ClinVar IDs not included.** Variants have `ClinVar_sig` classifications but no real ClinVar variation IDs. |
| - **PRS scores are simulated, not based on real GWAS effect sizes.** Distributions match published PRS percentile shapes but specific scores do NOT reflect real allele effects. |
| - **PGx phenotype calls follow CPIC frequency distributions but are NOT mechanistic.** Star allele class assignments are population-frequency-driven, not derived from underlying CYP/TPMT/etc. variant calls in `variants_annotated.csv`. |
| - **Synthetic, not derived from real biobank data.** Distributions match published gnomAD/ClinVar/CPIC/Tabula Sapiens references but do NOT reflect any specific real cohort (UK Biobank, All of Us, etc.). |
|
|
| --- |
|
|
| ## Ethical use guidance |
|
|
| This dataset is designed for: |
| - Genomic ML methodology development |
| - Clinical genomics pipeline testing |
| - PRS modeling research |
| - Pharmacogenomics CDS rule engine development |
| - scRNA-seq cell type annotation methodology |
| - Healthcare AI pretraining for genomic prediction tasks |
| - Educational use in clinical genomics, precision medicine, and biostatistics |
|
|
| This dataset is **not appropriate for**: |
| - Making clinical genetic diagnoses about real individuals |
| - Real PRS reporting for real patients without validated ancestry-matched reference panels |
| - Pharmacogenomic prescribing decisions for real patients without CPIC consultation |
| - Variant pathogenicity calls without ACMG framework validation on real ClinVar data |
| - Ancestry-based discriminatory modeling |
| - Population-genetic claims about real ethnic groups |
|
|
| --- |
|
|
| ## Companion datasets in the Healthcare vertical |
|
|
| - [HLT-001](https://huggingface.co/datasets/xpertsystems/hlt001-sample) — Synthetic Patient Population (CDC/NHANES) |
| - [HLT-002](https://huggingface.co/datasets/xpertsystems/hlt002-sample) — Synthetic EHR (FHIR R4) |
| - [HLT-003](https://huggingface.co/datasets/xpertsystems/hlt003-sample) — Synthetic Clinical Trial |
| - [HLT-004](https://huggingface.co/datasets/xpertsystems/hlt004-sample) — Synthetic Disease Progression |
| - [HLT-005](https://huggingface.co/datasets/xpertsystems/hlt005-sample) — Synthetic Hospital Admission |
| - [HLT-006](https://huggingface.co/datasets/xpertsystems/hlt006-sample) — Synthetic Medical Imaging |
| - [HLT-007](https://huggingface.co/datasets/xpertsystems/hlt007-sample) — Synthetic Drug Response |
| - [HLT-008](https://huggingface.co/datasets/xpertsystems/hlt008-sample) — Synthetic Healthcare Claims |
| - [HLT-009](https://huggingface.co/datasets/xpertsystems/hlt009-sample) — Synthetic ICU Vital Sign Monitoring |
| - [HLT-010](https://huggingface.co/datasets/xpertsystems/hlt010-sample) — Synthetic Hospital Resource Usage |
| - [HLT-011](https://huggingface.co/datasets/xpertsystems/hlt011-sample) — Synthetic Rare Disease + Trial Eligibility |
| - [HLT-012](https://huggingface.co/datasets/xpertsystems/hlt012-sample) — Synthetic Pandemic Spread |
| - **HLT-013** — Synthetic Multi-Modal Genomics (you are here) |
|
|
| Use **HLT-001 through HLT-013 together** for the full healthcare data stack — and HLT-013 specifically extends the catalog into **precision medicine & clinical genomics**, complementing HLT-007 (drug response with PGx hooks) and HLT-011 (rare disease with gene-variant calls). |
|
|
| --- |
|
|
| ## Citation |
|
|
| If you use this dataset, please cite: |
|
|
| ```bibtex |
| @dataset{xpertsystems_hlt013_sample_2026, |
| author = {XpertSystems.ai}, |
| title = {HLT-013 Synthetic Multi-Modal Genomics Dataset (Sample Preview)}, |
| year = 2026, |
| publisher = {Hugging Face}, |
| url = {https://huggingface.co/datasets/xpertsystems/hlt013-sample} |
| } |
| ``` |
|
|
| --- |
|
|
| ## Contact |
|
|
| - **Web:** [https://xpertsystems.ai](https://xpertsystems.ai) |
| - **Email:** [pradeep@xpertsystems.ai](mailto:pradeep@xpertsystems.ai) |
| - **Full product catalog:** Cybersecurity, Insurance & Risk, Materials & Energy, Oil & Gas, Healthcare, and more |
|
|
| **Sample License:** CC-BY-NC-4.0 (Creative Commons Attribution-NonCommercial 4.0) |
| **Full product License:** Commercial — please contact for pricing. |
|
|